Form 4: Repligen Corp Director Karen A. Dawes Reports Acquisition of Restricted Stock Units and Stock Options

Director Karen A. Dawes reports acquisition of 803 restricted stock units and 1,576 stock options in Repligen Corp.

Summary

• On May 16, 2024, Karen A. Dawes, a director of Repligen Corp, acquired 803 restricted stock units, each representing a contingent right to receive one share of Repligen Corporation's Common Stock.
• These restricted stock units vest on the earlier of May 16, 2025, or the date of the next annual meeting of the Company's shareholders.
• Dawes also acquired 1,576 stock options with an exercise price of $171.03.
• These options vest in full on the earlier of May 16, 2025, or the date of the next annual meeting of the Company's shareholders, and expire on May 16, 2034.
• Following these transactions, Dawes directly owns 88,170 shares of Repligen Corp common stock and 1,576 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of stock options and restricted stock units by a director can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of restricted stock units and stock options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon future events, specifically the earlier of May 16, 2025, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotechnology industry where equity compensation is frequently used.

Comparison to Industry Standards

• Equity compensation is a standard practice in the biotech industry to align the interests of management with those of shareholders.
• Companies like Amgen, Biogen, and Gilead Sciences also utilize stock options and restricted stock units as part of their compensation packages for directors and executives.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment as it indicates confidence from a company director.

Key Dates